Related Experiment Video
Updated: Jun 15, 2026
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
Published on: May 6, 2020
A pathway and approach to biomarker validation and qualification for osteoarthritis clinical trials
David J Hunter1, Elena Losina, Ali Guermazi
1Division of Research, New England Baptist Hospital, 125 Parker Hill Ave, Boston MA 02120, USA. djhunter@caregroup.harvard.edu
Abstract:
This narrative review outlines the work done in other fields with regards biomarker validation and qualification and the lessons that we may learn from this experience. Defining a universally agreed upon path for biomarker validation and qualification is urgently needed to circumvent many of the hurdles faced in OA therapeutic development irrespective of whether we are discussing biochemical markers, imaging markers or other measures. This review proposes a path that may be suitable for osteoarthritis and poses some logical next steps that will take us in this direction.